3DandonaP.Procalcitionin increase after endotoxin injection in normalsubjectsfj].Journal of Clinical Endocrinology and Metabolism, 1994,79(6): 1605-1608.
4SchuetzP, Batschwaroff M, Dusemund F,et al.Effectiveness of aprocalcitonin algorithm to guide antibiotic therapy in respiratory tractinfectious outside of study conditions: a post-study survey[J].Eur J ClinMicrobiol Dis, 2010,29(3): 269-277.
1Windgassen EB,Funtowicz L,Lunsford TN,et al.C-reactive protein and high-sensitivity C-reactive protein:an update for clinicians.Postgrad Med,2011,123(1):114-119.
2Kurata K,Kazuyori T,Shimizu K,et al.Usefulness of serum procalcitonin measurement in the diagnosis of respiratory infectious diseases.Nihon Kokyuki Gakkai Zasshi,2010,48(9):654-660.
3Cuquemelle E,Soulis F,Villers D,et al.Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia?A multicentre study.Intensive Care Med,2011,37(5):796-800.
4Indino P,Lemarchand P,Bady P,et al.Prospective study on p ro-calcitonin and other systemic infection markers in patients with leukocytosis.Int J Infect Dis,2008,12(3):3192-3324.
5Didebulidze K,Manjavidze N,Ubiria I,et al.Procalciton in marker of severe infection and sep sis.Georgian Med News,2007,11(153):22-27.
6Schuetz P,Christ-Crain M,Wolbers M,et al.Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections:a prospective,multicenter,randomized controlled trial.BMC Health Serv Res,2007,7:102.
7Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection [ J ]. Pediatr Infect Dis J,2000,19:679 - 688.
8Pavord ID, Pizzichini MM, Pizzichini E,et al. The use of induced sputum to investigate airway inflammation [ J ]. Thorax, 1997,52 :498 - 501.
9Pye A, Stockley RA, Hill S. Simple method for quantifying viable bacteria numbers in sputum [ J ]. J Clin Pathol, 1995,48 ; 719 -724.
10Stockley RA, O Brien C, Pye A, et al. Relationship of sputum color to nature and outpatient management of acute exacerbation of chronic obstructive pulmonary disease [ J ]. Chest, 2000,117 : 1638- 1645.
4Foushee JA,Hope NH,Grace EE. Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays [J ]. J Antimicrob Chemother, 2012,67( 11 ) :2560-2569.
5Kurata K, Kazuyori T,Shimizu K, et al. Usefulness of serum proealeitonin measurement in the'diagnosis of respiratory in- feetious diseases[J]. Nihon Kokyuki Gakkai Zasshi,2010,48 ( 9 ) : 654-660.
6Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeu- tic target[ J ]. Br J Pharmacol, 2010,159(2) : 253-264.
7Kamine Akari,Shimozuru Michito,Shibata Haruki,et al.Effects of intramuscular administration of tiletamine-zolazepam with and without sedative pretreatment on plasma and serum biochemical values and glucose tolerance test results in Japanese black bears(Ursus thibetanus japonicas)[J].American Journal of Veterinary Research,2012,73(8):172-175.
8Yanchen Zhou,Imke Steffen,Leilani Montalvo,et al.Development and application of a high-throughput microneutralization assay:lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors[J].Transfusion,2012,52(2):332-342.
9Yanchen Zhou,Imke Steffen,Leilani Montalvo,et al.Development and application of a high-throughput microneutralization assay:lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors[J].Transfusion,2012,52(2):332-342.
10Oberhoffer M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitrorJ]. J Lab Clin Med,1999,134(1):49-55.
